Reportedly, increased fatty acid synthase (FASN) activity has been shown in breast cancer cell lines (102), ovarian tumors (103), or cancer precursor lesions in different locations (colon, stomach, esophagus, and oral cavity) (104). This evidence concerns the gene FASN and breast carcinoma.